查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
静脉注射解决方案市场，按类型、营养素、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351416

静脉注射解决方案市场，按类型、营养素、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Intravenous Solutions Market, By Type, By Nutrients, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 307 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年静脉注射解决方案市场规模为1,191,011万美元，2023年至2030年复合年增长率为8.11%。

在医疗保健领域，静脉输液在各种医疗环境中发挥关键作用，包括医院、诊所和急诊室。它们的重要性在于它们能够维持和调节适当的液体平衡，支持关键的生理过程，并确保治疗化合物和营养物质的有效分配。

静脉解决方案市场 - 市场动态：

  • 神经系统疾病、胃肠道疾病和癌症等疾病的发生率增加
  • 静脉注射液市场的强劲扩张可归因于各种疾病的盛行率激增，包括胃肠道疾病、神经系统疾病和癌症。这些情况通常需要使用静脉治疗来有效给药和补充水分。因此，静脉注射液的需求显着增加，静脉注射液是病人的重要生命线。这种需求的增加不仅改善了患者护理，还推动了市场成长，因为医疗保健专业人员越来越依赖这些解决方案来管理各种医疗状况。
  • 根据全球健康数据，世界卫生组织（WHO）报告称，2018年全球癌症发病率超过1810万例，预计到2034年这一数字将激增至2200万例。此外，世界卫生组织的统计数据表明，胃肠道疾病影响癌症患者的健康。美国估计有 6000 至 7000 万人。这种流行凸显了对肠外营养解决方案（包括葡萄糖、磷脂质、麸酰胺酸和胺基酸）的日益增长的需求，以满足患者的医疗保健需求。

静脉解决方案市场 - 主要见解：

  • 根据我们的研究分析师提供的见解，全球静脉注射解决方案市场预计将经历强劲的年度成长，在 2023 年至 2030 年的预测期内，预计复合年增长率 (CAGR) 约为 7.9%。
  • 该行业的成长轨迹受到重要因素的支撑，主要是神经系统疾病、胃肠道疾病和癌症等各种医疗状况的盛行率不断上升。
  • 就产品分类而言，全肠外营养领域成为 2022 年市占率的主要贡献者。
  • 此外，在考虑营养成分细分时，单剂量胺基酸类别在 2022 年表现出了其突出地位。
  • 从地理位置来看，北美将在 2022 年成为该市场的主要创收区域。

静脉注射解决方案市场-細項分析：

  • 全球静脉注射解决方案市场呈现三个关键维度的细分：类型、营养和地理区域。
  • 就类型分类而言，市场可分为全肠外营养和周边肠外营养。全肠外营养涉及绕过消化系统将营养液直接输送到血液中。这些解决方案的管理通常是根据个人的体重、年龄、身高和特定医疗状况等因素量身定制的。这些解决方案广泛用于胃肠道疾病的治疗、烧伤的治疗、肠道综合症的治疗、支持接受化疗的患者以及促进术后復健。

静脉解决方案市场-竞争格局：

企业采用多种策略将产品推向市场，利用企业网站、电子商务平台、零售合作伙伴、经销商和直接面向消费者的方式等多种管道。产品製造商之间的竞争集中在各种因素，包括定价、性能、製造流程、技术进步、品牌声誉和产品可用性。为了巩固市场份额并扩大份额，公司采用了一系列策略。其中包括推出新产品、扩大分销网络、大力投资研发、进行併购。

例如，2022 年 2 月，贝朗医疗获得美国食品药物管理局的批准，在佛罗里达州代托纳比奇新建的静脉注射盐溶液生产工厂开始运作。在 2021 年 9 月的另一个例子中，B. Braun Medical Inc. 推出了 CARESAFE IV Administration Sets，具有可选的 AirStop 组件，增强了其产品组合。

目录

第 1 章：静脉注射解决方案市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的静脉注射解决方案市场片段
    • 静脉注射解决方案市场片段（按营养素）
    • 按国家/地区分類的静脉注射解决方案市场片段
    • 按地区分類的静脉注射解决方案市场片段
  • 竞争洞察

第 3 章：静脉注射解决方案主要市场趋势

  • 静脉注射解决方案市场驱动因素
    • 市场驱动因素的影响分析
  • 静脉注射解决方案市场限制
    • 市场限制影响分析
  • 静脉注射解决方案市场机会
  • 静脉注射解决方案市场未来趋势

第 4 章：静脉注射解决方案产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：静脉解决方案市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：静脉解决方案市场格局

  • 2022 年静脉解决方案市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：静脉解决方案市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 全肠外营养
    • 週边肠外营养

第 8 章：静脉注射解决方案市场 - 按营养成分

  • 概述
    • 按营养成分分類的细分市场份额分析
    • 单剂量氨基酸溶液
    • 碳水化合物
    • 肠外脂质乳剂
    • 维生素和矿物质
    • 其他的

第 9 章：静脉注射解决方案市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美静脉注射解决方案主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测（按营养成分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲静脉注射解决方案主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按营养成分）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区静脉注射解决方案主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（依营养成分）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲静脉注射解决方案主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按营养成分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲静脉注射解决方案主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按营养成分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 静脉注射解决方案产业

  • 竞争仪表板
  • 公司简介
    • Vifor Pharma Group
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • Terumo Corporation
    • Smiths Medical (a division of Smiths Group plc)
    • Sippex Pharmaceuticals Pvt. Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • JW Pharmaceutical Corporation
    • ICU Medical, Inc.
    • Hospira (now part of Pfizer Inc.)
    • Grifols SA
    • Fresenius SE & Co. KGaA
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Amanta Healthcare Ltd.

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1664

REPORT HIGHLIGHT

Intravenous Solutions Market size was valued at USD 11,910.11 Million in 2022, expanding at a CAGR of 8.11% from 2023 to 2030.

Intravenous infusion solutions, commonly referred to as IV infusions, are sterile liquid formulations administered directly into a patient's bloodstream through a needle or catheter. These specialized solutions are meticulously crafted to provide essential hydration, replenish vital electrolytes, and facilitate the delivery of medications or essential nutrients when a patient cannot ingest them orally.

Within the realm of healthcare, IV infusions play a pivotal role across various medical settings, encompassing hospitals, medical clinics, and emergency care units. Their significance lies in their ability to uphold and regulate proper fluid balance, support crucial physiological processes, and ensure the efficient dispensation of therapeutic compounds and nutrients.

Intravenous Solutions Market - Market Dynamics:

  • Increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer
  • The robust expansion of the Intravenous Solutions market can be attributed to the surging prevalence of various medical conditions, including gastrointestinal disorders, neurological ailments, and cancer. These conditions often necessitate the use of intravenous therapy for effective medication administration and hydration. Consequently, there has been a notable escalation in the demand for intravenous solutions, which serve as a crucial lifeline for patients. This heightened demand not only improves patient care but also fuels market growth, as healthcare professionals increasingly rely on these solutions to manage a wide spectrum of medical conditions.
  • In line with global health data, the World Health Organization (WHO) reported that the global incidence of cancer exceeded 18.1 million cases in 2018, and this figure is projected to surge to 22.0 million by 2034. Furthermore, WHO statistics indicate that gastrointestinal diseases affect an estimated 60 to 70 million individuals in the United States. This prevalence underscores the growing need for parenteral nutritional solutions, encompassing glucose, phospholipids, glutamine, and amino acids, to address the healthcare requirements of patients.

Intravenous Solutions Market - Key Insights:

  • According to insights provided by our research analysts, the global Intravenous Solutions market is anticipated to experience robust annual growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 7.9% during the forecast period spanning from 2023 to 2030.
  • This industry's growth trajectory is underpinned by significant factors, primarily the escalating prevalence of various medical conditions such as neurological disorders, gastrointestinal ailments, and cancer.
  • In terms of product categorization, the segment dedicated to total parenteral nutrition emerged as the leading contributor to market share for the year 2022.
  • Furthermore, when considering nutrient segmentation, the single-dose amino acid category demonstrated its prominence in 2022.
  • Geographically, North America emerged as the primary revenue-generating region for the market in the year 2022.

Intravenous Solutions Market- Segmentation Analysis:

  • The worldwide Intravenous Solutions Market exhibits segmentation across three key dimensions: Type, Nutrient, and Geographic Region.
  • In terms of Type classification, the market can be categorized into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total Parenteral Nutrition involves the direct delivery of nourishing fluids into the bloodstream, bypassing the digestive system. The administration of these solutions is typically customized based on factors such as an individual's weight, age, height, and specific medical condition. These solutions find extensive use in the management of gastrointestinal disorders, treatment of burn injuries, addressing bowel syndromes, supporting patients undergoing chemotherapy, and facilitating post-surgical recovery.

Intravenous Solutions Market- Competitive Landscape:

Businesses employ a diverse array of strategies to bring their products to market, leveraging multiple channels like corporate websites, e-commerce platforms, retail partners, distributors, and direct-to-consumer approaches. Competition among product manufacturers centers on various factors encompassing pricing, performance, manufacturing processes, technological advancements, brand reputation, and product availability. To fortify their market presence and broaden their share, companies employ a range of tactics. These include the introduction of new products, the expansion of distribution networks, significant investments in research and development, and engaging in mergers and acquisitions.

For example, in February 2022, B. Braun Medical secured approval from the US Food and Drug Administration to initiate operations at their newly established IV saline solution production facility in Daytona Beach, Florida. In a separate instance from September 2021, B. Braun Medical Inc. unveiled CARESAFE IV Administration Sets, featuring an optional AirStop component, enhancing their product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS SOLUTIONS MARKET KEY PLAYERS

  • Vifor Pharma Group
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Terumo Corporation
  • Smiths Medical (a division of Smiths Group plc)
  • Sippex Pharmaceuticals Pvt. Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • JW Pharmaceutical Corporation
  • ICU Medical, Inc.
  • Hospira (now part of Pfizer Inc.)
  • Grifols S.A.
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Amanta Healthcare Ltd.

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY NUTRIENT

  • Single-Dose Amino Acid Solutions
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Vitamins & Minerals
  • Others

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Intravenous Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intravenous Solutions Market Snippet by Type
    • 2.1.2. Intravenous Solutions Market Snippet by Nutrient
    • 2.1.3. Intravenous Solutions Market Snippet by Country
    • 2.1.4. Intravenous Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Intravenous Solutions Key Market Trends

  • 3.1. Intravenous Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intravenous Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intravenous Solutions Market Opportunities
  • 3.4. Intravenous Solutions Market Future Trends

4. Intravenous Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intravenous Solutions Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intravenous Solutions Market Landscape

  • 6.1. Intravenous Solutions Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intravenous Solutions Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Total Parenteral Nutrition
    • 7.1.3. Peripheral Parenteral Nutrition

8. Intravenous Solutions Market - By Nutrient

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Nutrient, 2022 & 2030 (%)
    • 8.1.2. Single-Dose Amino Acid Solutions
    • 8.1.3. Carbohydrates
    • 8.1.4. Parenteral Lipid Emulsion
    • 8.1.5. Vitamins & Minerals
    • 8.1.6. Others

9. Intravenous Solutions Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Intravenous Solutions Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Intravenous Solutions Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Intravenous Solutions Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Intravenous Solutions Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Intravenous Solutions Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Intravenous Solutions Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vifor Pharma Group
    • 10.2.2. Vetter Pharma-Fertigung GmbH & Co. KG
    • 10.2.3. Terumo Corporation
    • 10.2.4. Smiths Medical (a division of Smiths Group plc)
    • 10.2.5. Sippex Pharmaceuticals Pvt. Ltd.
    • 10.2.6. Sichuan Kelun Pharmaceutical Co., Ltd.
    • 10.2.7. Otsuka Pharmaceutical Co., Ltd.
    • 10.2.8. JW Pharmaceutical Corporation
    • 10.2.9. ICU Medical, Inc.
    • 10.2.10. Hospira (now part of Pfizer Inc.)
    • 10.2.11. Grifols S.A.
    • 10.2.12. Fresenius SE & Co. KGaA
    • 10.2.13. Baxter International Inc.
    • 10.2.14. B. Braun Melsungen AG
    • 10.2.15. Amanta Healthcare Ltd.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Intravenous Solutions Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Intravenous Solutions Market, by Type 2018-2030 (USD Million)
  • TABLE Intravenous Solutions Market: Nutrient Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Nutrient
  • TABLE Global Intravenous Solutions Market, by Nutrient 2018-2030 (USD Million)
  • TABLE Intravenous Solutions Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Intravenous Solutions Market, by Region 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Intravenous Solutions Market, by Nutrient, 2018-2030 (USD Million)